A new report from Avalere finds that under current law Medicare beneficiaries are likely to pay more for biosimilars than for the biologic reference product in Part D.
A new Avalere analysis finds that 60 percent of hospitals participating in Medicare’s Comprehensive Care for Joint Replacement (CJR) model could face penalties based on their cost performance.
A new analysis from Avalere Health finds that hospitals and health systems are increasingly taking risk for the cost of Medicare patients and the quality of the care they receive.
Avalere Health has estimated the cost savings that could result from a new, less-expensive tier of insurance coverage, if legislation were to permit it. Currently, the Affordable Care Act requires all health plans offered in the individual and small group markets to meet standards for bronze, sil
The Halbig v. Burwell case before the U.S.
A new analysis from Avalere Health finds that average proposed premiums for individual market exchange plans will increase modestly in 2015, based
A new analysis from Avalere Health finds that proposed rate increases
New Avalere analysis finds that exchange enrollment is on track to reach 5.4 million by the end of March when open enrollment is set to end. That number falls short of current Congressional Budget Office (CBO) estimates that six million people will enroll in exchanges in 2014.
